Cargando…
Modulation of microRNA Expression in Subjects with Metabolic Syndrome and Decrease of Cholesterol Efflux from Macrophages via microRNA-33-Mediated Attenuation of ATP-Binding Cassette Transporter A1 Expression by Statins
Metabolic syndrome (MetS) is a complicated health problem that encompasses a variety of metabolic disorders. In this study, we analyzed the relationship between the major biochemical parameters associated with MetS and circulating levels of microRNA (miR)-33, miR-103, and miR-155. We found that miRN...
Autores principales: | Chen, Wei-Ming, Sheu, Wayne H-H, Tseng, Pei-Chi, Lee, Tzong-Shyuan, Lee, Wen-Jane, Chang, Pey-Jium, Chiang, An-Na |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4854384/ https://www.ncbi.nlm.nih.gov/pubmed/27139226 http://dx.doi.org/10.1371/journal.pone.0154672 |
Ejemplares similares
-
MicroRNA-33-5p inhibits cholesterol efflux in vascular endothelial cells by regulating citrate synthase and ATP-binding cassette transporter A1
por: Xie, Qiong, et al.
Publicado: (2021) -
Differential expression of microRNA-675, microRNA-139-3p and microRNA-335 in benign and malignant adrenocortical tumours
por: Schmitz, K J, et al.
Publicado: (2011) -
MicroRNA-33 suppresses CCL2 expression in chondrocytes
por: Wei, Meng, et al.
Publicado: (2016) -
The Expression of microRNA and microRNA Clusters in the Aging Heart
por: Zhang, Xiaomin, et al.
Publicado: (2012) -
Aberrant expression of plasma microRNA-33a in an atherosclerosis-risk group
por: Kim, Soo Hwan, et al.
Publicado: (2016)